OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. A variety of strategies have been employed enhance antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion systems. Fine-tuning media composition p